ProfileGDS4718 / 204642_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 47% 64% 45% 48% 34% 48% 40% 51% 48% 52% 57% 42% 49% 40% 55% 59% 54% 38% 65% 46% 51% 46% 58% 53% 38% 60% 31% 46% 30% 36% 51% 43% 37% 49% 54% 38% 62% 44% 75% 52% 42% 54% 41% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3723147
GSM549102patient 115, normal, homogenized [OPG study]5.3771647
GSM549104patient 119, normal, homogenized [OPG study]6.424864
GSM549108patient 138, normal, homogenized [OPG study]5.2834945
GSM549119patient 077, normal, homogenized [OPG study]5.4061548
GSM549133patient 032, cancer, homogenized [OPG study]4.6643734
GSM549139patient 042, cancer, homogenized [OPG study]5.3658248
GSM549099patient 107, normal, homogenized [OPG study]4.9909440
GSM549109patient 139, normal, homogenized [OPG study]5.5648951
GSM549110patient 046, normal, homogenized [OPG study]5.3797948
GSM549114patient 063, normal, homogenized [OPG study]5.5909452
GSM549122patient 082, normal, homogenized [OPG study]5.9363157
GSM549134patient 033, cancer, homogenized [OPG study]5.0900842
GSM549136patient 036, cancer, homogenized [OPG study]5.4066749
GSM549140patient 044, cancer, homogenized [OPG study]4.9668940
GSM549111patient 047, normal, homogenized [OPG study]5.7832855
GSM549113patient 057, normal, homogenized [OPG study]6.0599159
GSM549132patient 031, cancer, homogenized [OPG study]5.7187354
GSM549137patient 038, cancer, homogenized [OPG study]4.8497638
GSM549142patient 047, cancer, homogenized [OPG study]6.5256665
GSM549100patient 110, normal, homogenized [OPG study]5.3297246
GSM549107patient 135, normal, homogenized [OPG study]5.5417551
GSM549115patient 068, normal, homogenized [OPG study]5.2147846
GSM549116patient 072, normal, homogenized [OPG study]5.9927758
GSM549120patient 078, normal, homogenized [OPG study]5.7075753
GSM549131patient 030, cancer, homogenized [OPG study]4.8210738
GSM549118patient 074, normal, homogenized [OPG study]6.1305160
GSM549129patient 027, cancer, homogenized [OPG study]4.6078331
GSM549123patient 088, normal, homogenized [OPG study]5.2556746
GSM549124patient 006, cancer, homogenized [OPG study]4.5702230
GSM549126patient 015, cancer, homogenized [OPG study]4.8081536
GSM549128patient 025, cancer, homogenized [OPG study]5.5581451
GSM549103patient 117, normal, homogenized [OPG study]5.1951643
GSM549117patient 073, normal, homogenized [OPG study]4.8325537
GSM549138patient 041, cancer, homogenized [OPG study]5.4505749
GSM549141patient 045, cancer, homogenized [OPG study]5.7256254
GSM549130patient 028, cancer, homogenized [OPG study]4.8812338
GSM549101patient 111, normal, homogenized [OPG study]6.3189562
GSM549105patient 128, normal, homogenized [OPG study]5.2279344
GSM549106patient 134, normal, homogenized [OPG study]7.4137375
GSM549112patient 048, normal, homogenized [OPG study]5.6003652
GSM549125patient 011, cancer, homogenized [OPG study]5.1270142
GSM549127patient 024, cancer, homogenized [OPG study]5.7763854
GSM549135patient 035, cancer, homogenized [OPG study]5.0082641